N. Dana, G. Vaseghi, and shaghayegh haghjooy javanmard, “PPAR γ agonist, pioglitazone, suppresses melanoma cancer in mice by inhibiting TLR4 signaling”, J Pharm Pharm Sci, vol. 22, no. 1, pp. 418–423, Sep. 2019.